Evidence map›Paper›PMID 41366524›Full record

ArticleJournal of epidemiology and global health2025

Post-COVID-19 Seasonality of Influenza, Respiratory Syncytial Virus, and SARS-CoV-2 Among Hospitalized Children in Western Iran: A Molecular Surveillance Study (2023-2024).

Ensieh Masoorian, Ali Teimoori, Somaye Bakhtiari, Farid Azizi Jalilian, Roya Najafi Vosough, Nastaran Ansari

Abstract read
In one paragraph

Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ensieh MasoorianDepartment of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Fahmideh Street, Hamadan, Iran.
Ali TeimooriDepartment of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Fahmideh Street, Hamadan, Iran.
Somaye BakhtiariReference Laboratory of Public Health, Hamadan University of Medical Sciences, Fahmideh Street, Hamadan, Iran.
Farid Azizi JalilianDepartment of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Fahmideh Street, Hamadan, Iran.
Roya Najafi VosoughResearch Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
Nastaran AnsariDepartment of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Fahmideh Street, Hamadan, Iran. na.ansari@umsha.ac.ir.ORCID http://orcid.org/0000-0002-0233-6494

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to characterize the incidence, seasonality, and co-infection patterns of respiratory syncytial virus (RSV), influenza A and B, and SARS-CoV-2 among hospitalized children aged 0-5 years in Hamedan Province, a semi-arid region in western Iran, from April 2023 to March 2024. Key research questions included assessing post-pandemic shifts in viral seasonality, evaluating the extent of RSV circulation, and determining the frequency of co-infections in a resource-limited pediatric setting where regional data remain scarce.

methodsA total of 586 nasopharyngeal/oropharyngeal samples were collected from children aged 0-5 years hospitalized with acute respiratory symptoms (≥ 2 of: fever ≥ 38 °C, cough, dyspnea, oxygen saturation < 95%). Multiplex real-time PCR (sensitivity 95%, specificity 98%) was used to detect RSV, SARS-CoV-2, and influenza A (H1N1, H3N2) and B. Statistical analysis included chi-square and Fisher's exact tests, and generalized linear models (binomial distribution, logit link).

resultsAmong 586 inpatients (mean age: 2.8 years; 62.5% male), 27.0% tested positive for influenza (60% influenza A [35% H1N1, 25% H3N2], 40% influenza B), 6.0% for RSV, and 6.3% for SARS-CoV-2. Influenza peaked in autumn (41.3%, p < 0.001), RSV in winter (18.2%, p < 0.001), and SARS-CoV-2 in spring (15.3%, p = 0.005). Co-infections were rare (0.9%).

conclusionsFindings reveal altered post-pandemic seasonality, reduced RSV activity, and low co-infection rates, suggesting potential ecological and immunological shifts. These trends highlight the need for sustained virus-specific surveillance and recalibrated vaccination strategies-particularly influenza vaccination in autumn and RSV prophylaxis in winter-in resource-limited pediatric settings.

Indexed as

CoinfectionCOVID-19Influenza, HumanRespiratory Syncytial Virus InfectionsChild, HospitalizedChild, PreschoolFemaleHospitalizationHumansIncidenceInfantInfant, NewbornIranMaleRespiratory Syncytial Virus, HumanSARS-CoV-2EpidemiologyInfluenza A and BIranPediatric hospitalizationPost-COVID-19 surveillanceRespiratory syncytial virus (RSV)SARS-CoV-2Seasonality

Identifiers

PMID41366524
PMCPMC12696241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.